Recap: Eli Lilly Q3 Earnings

Eli Lilly LLY reported its Q3 earnings results on Tuesday, November 1, 2022 at 06:25 AM.

Here's what investors need to know about the announcement.

Eli Lilly beat estimated earnings by 3.12%, reporting an EPS of $1.98 versus an estimate of $1.92.

Revenue was up $168.80 million from the same period last year.

Last quarter the company missed on EPS by $0.44 which was followed by a 1.46% drop in the share price the next day.

Here's a look at Eli Lilly's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	1.69	2.13	2.19	1.68
EPS Actual	1.25	2.62	2.49	1.94
Revenue Estimate	6.70B	6.68B	6.90B	5.70B
Revenue Actual	6.49B	7.81B	8.00B	6.77B

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Eli Lilly management provided guidance for FY 2022, expecting earnings between $7.7 and $7.85 per share.

To track all earnings releases for Eli Lilly visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar